-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.O1.6 613. Acute Myeloid Leukemias: Clinical and Epidemiological: Clinical Care and Observations in Acute Myeloid Leukemia

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, Clinical Practice (Health Services and Quality), APL, epidemiology, elderly, Clinical Research, health outcomes research, Diseases, real-world evidence, Adverse Events, Myeloid Malignancies, survivorship, Study Population, Human
Sunday, December 11, 2022: 9:30 AM-11:00 AM
278-282 (Ernest N. Morial Convention Center)
Moderators:
Andreas Neubauer, MD, Philipps University and Arjun D. Law, MD, Princess Margaret Cancer Centre, University Health Network
Disclosures:
Law: Jazz Educational: Consultancy, Membership on an entity's Board of Directors or advisory committees; Kite Gilead: Consultancy, Membership on an entity's Board of Directors or advisory committees; Atara: Research Funding; Incyte Corporation: Research Funding; Sierra: Research Funding; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees.
This session includes studies that highlight important clinical observations for the care and treatment of patients with acute myeloid leukemia (AML)
9:30 AM

Anand P. Jillella, MD1, Sandra J. Lee, ScD2*, Jessica K. Altman, MD3, Selina M. Luger, MD, FRCPC4, Martin S. Tallman, MD5, James M. Foran, MD6, Lisa Y. Law, MD7, Locke J. Bryan, MD1, Abdallah Abou Zahr, MD8*, Kebede Begna, MD9, Alexander Perl, MD10, Joseph Vadakara, MD11, Federico Sanchez, MD12*, Raymond C. Bergan, MD13*, Michael J. Fisch, MD14*, Ruth C. Carlos, MD15*, Lynne I. Wagner, PhD16*, Mark R. Litzow, MD17 and Vamsi K. Kota, MD1

1Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
2Dana Farber Cancer Institute, Boston, MA
3Northwestern University, Chicago, IL
4Cellular Therapy and Transplantation, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
5Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
7Kaiser Permanente, Roseville, CA
8Sanford Roger Maris Cancer Center, Fargo, ND
9Divison of Hematology, Mayo Clinic, Rochester, MN
10Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
11Cancer Institute, Geisinger Medical Center, Danville, PA
12Aurora Saint Luke's Medical Center, Wauwatosa, WA
13University of Nebraska Medical Center, Omaha, NE
14MD Anderson Cancer Center, Houston, TX
15University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
16Wake Forest School of Medicine, Winston Salem, NC
17Division of Hematology, Mayo Clinic, Rochester, MN

9:45 AM

Kelly D. Getz, PhD, MPH1,2*, Robert B. Gerbing, MA3*, Todd A. Alonzo, PhD4*, Yimei Li, PhD5,6*, Kasey J Leger, MD, MSc7, Jessica A. Pollard, MD8,9, Dava Szalda, MD MSHP10*, Lillian Sung, MD, PhD11, Todd M. Cooper, DO7, Edward A. Kolb, MD12, Alan S. Gamis, MD, MPH13, Bonnie Ky, MD14* and Richard Aplenc, MD, PhD10

1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
2Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA
3Children's Oncology Group, Monrovia, CA
4Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
5Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
6Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
7Seattle Children's Hospital, Seattle, WA
8Dana Building 3136, Dana-Farber Cancer Institute, Boston, MA
9Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
10Children's Hospital of Philadelphia, Philadelphia, PA
11The Hospital for Sick Children, Toronto, ON, CAN
12Division of Oncology, Nemours Alfed I. duPont Hospital For Children, Wilmington, DE
13Hematology/Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO
14Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA

10:00 AM

Evangelia Antoniou, MD1,2, Annika Puschnig1*, Katharina Waack2*, Carolin Augsburg2*, Christel Katerkamp1,2*, Denise Kondryn2*, Tabea Ziedrich1,2*, Nils von Neuhoff, PhD2*, Dirk Reinhardt, MD1,2 and Stephanie Sendker, MD2*

1Clinic of pediatrics III, University Hospital of Essen, Essen, Germany
2AML-BFM study group, Essen, Germany

10:15 AM

Ga-Young Song, MD1*, Taehyung Kim, MSc2,3, Seo-Yeon Ahn, MD4*, Sung-Hoon Jung, MD5*, Mihee Kim, MD6*, Deok-Hwan Yang, MD, PhD4*, Je-Jung Lee, MD, PhD4, Seunghyun Choi, PhD7*, MiYeon Kim7*, Chul Won Jung, MD, PhD8*, Jun-Ho Jang, MD8*, Heeje Kim, MD, PhD9, Joon Ho Moon, MD10, Sang Kyun Sohn11*, Jong Ho Won, MD, PhD12, Seongkyu Park13*, Sung-Hyun Kim, MD, PhD14, Zhaolei Zhang, PhD2,15,16*, Jae-Sook Ahn, MD, PhD17,18*, Hyeoung-Joon Kim, MD, PhD4,17 and Dennis D. H. Kim19

1Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-Do, KOR
2Department of Computer Science, University of Toronto, Toronto, ON, Canada
3The Donnelly Centre for Cellular and Biomolecular Research, Donnelly Centre For Cellular & Biomolecular Research, Toronto, ON, Canada
4Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of (South)
5Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Jeollanamdo, Korea, Republic of (South)
6Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University, Hwasun-Gun, Jeollanam-Do,, AL, Korea, Republic of (South)
7Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun-gun, Korea, Republic of (South)
8Division of Hematology-Oncology, Samsung Medical Center, Seoul, Korea, Republic of (South)
9Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic Univ. of Korea, Seoul, Korea, Republic of (South)
10Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
11Department of Hematology–Oncology, Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
12Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang university hospital Seoul, Seoul, Korea, Republic of (South)
13Soon Chun Hyang University Hospital, Hematology Oncology, Internal Medicine, Seoul, KOR
14Department of Hematology-Oncology, Dong-A University College of Medicine, Dong-A University Hospital, Busan, Korea, Republic of (South)
15Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
16The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada
17Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of (South)
18Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun-Gun, Jeollanam-Do, Korea, Republic of (South)
19Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada

10:30 AM

Daehun Kwag1,2*, Su Yeon Bang, MD1,2*, Jong Hyuk Lee, MD1,2*, Gi June Min, M.D., Ph.D.1,2*, Sung-Soo Park, M.D., Ph.D.1,2*, Silvia Park, M.D., Ph.D.1,2*, Jae-Ho Yoon, M.D., Ph.D.1,2, Sung-Eun Lee, MD1,2*, Ki-Seong Eom, M.D., Ph.D.1,2*, Yoo-Jin Kim, M.D., Ph.D.1,2, Seok Lee, M.D., Ph.D.1,2, Heeje Kim, M.D., Ph.D.1,2, Chang-Ki Min, MD, PhD1,2*, Seok-Goo Cho, M.D., Ph.D.2,3*, Jong Wook Lee, M.D., Ph.D.1 and Byung-Sik Cho, M.D., Ph.D.1,2*

1Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

10:45 AM

Andrew Matthews, MD1, Alexander E. Perl, MD1, Selina M. Luger, MD, FRCPC1,2, Saar Gill, MD, PhD1, Catherine Lai, MD, MPH1, David L. Porter, MD1, Sarah Skuli, MD, PhD1, Ximena Jordan Bruno1*, Craig W. Freyer, PharmD3*, Alison Carulli, PharmD1*, Martin P. Carroll, MD1, Daria V. Babushok, MD1, Noelle V. Frey, MD, MS1, Elizabeth O. Hexner, MD, MSTR1, Mary Ellen Martin, MD1, Shannon R. McCurdy, MD1, Edward A. Stadtmauer, MD1, Alison W. Loren, MD1, Vikram R Paralkar, MD1, Ivan Maillard, MD, PhD1 and Keith W. Pratz, MD1

1Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
2Internal Medicine, Abramson Cancer Center, University of Pennsyvania, Philadelphia, PA
3Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA

*signifies non-member of ASH